Table 2 Literature review of surgical treatment for pancreatic metastases from RCC
Reference | Year | Number of patientsa | Median age | Sex (F:M) | 5-year survival | Median survival (months) | Time from primary treatment (months) | Median follow-up period (months) |
|---|---|---|---|---|---|---|---|---|
Butturini et al.[53] | 1998 | 5 | 63 | 2:3 | NA | 24.5 | 120 (24–276) | 19 |
Kassabian et al.[54] | 2000 | 5 | 56 | 1:4 | 67% | NA | 144 (48–180) | 48 |
Ghavamian et al.[55] | 2000 | 11 | 68 | 3:8 | 81% | 120 | 108 (18–295) | 50 |
Sohn et al.[17] | 2001 | 10 | 63 | 4:6 | 80% | 7 | 102 (0–336) | 8 |
Faure et al.[36] | 2001 | 8 | 57 | 2:6 | 88% | NA | 83 (12–120) | 38 |
Yachida et al.[37] | 2002 | 5 | 60 | 2:3 | 100% | 12 | 144 (36–288) | 18 |
Law et al.[56] | 2003 | 14 | 64 | 9:5 | 75% | NA | 78 (0–300) | 130 |
Wente et al.[47] | 2005 | 15 | 63 | 10:5 | NA | NA | 85 (0–258) | 10 |
Crippa et al.[6] | 2006 | 5 | 65 | 3:2 | 80% | NA | 36 (22–192) | 41 |
Eidt et al.[15] | 2007 | 7 | 64 | 2:5 | 88% | NA | 160 (108–240) | 36 |
Varker et al.[57] | 2007 | 5 | NA | NA | 60% | NA | 175 | NA |
Schauer et al.[58] | 2008 | 10 | 62 | 5:5 | 60% | 33 | 128 (5–277) | 56 |
Zerbi et al.[14] | 2008 | 23 | 64 | 15:8 | 88% | 27 | 96 (12–276) | 31 |
Reddy et al.[27] | 2008 | 21 | 60 | 11:10 | 45% | 58 | 110 | over 120 |
Tanis et al.[49] | 2009 | 10 | 63.5 | 2:8 | NA | NA | 107 (5–228) | NA |
Masetti et al.[48] | 2010 | 6 | 62 | 6:0 | NA | NA | 57.6 (20–288) | 3 |
Konstantinidis et al.[59] | 2010 | 20 | 68.5 | 7:13 | 61% | 104 | 104 | NA |
Yazbek et al.[44] | 2012 | 11 | 73 | 1:10 | 90% | 84 | 136 (12–240) | NA |
Gardini et al.[60] | 2012 | 8 | 68 | 4:4 | NA | NA | NA | 38.6 |